PMID- 28218579 OWN - NLM STAT- MEDLINE DCOM- 20171207 LR - 20221207 IS - 1488-2353 (Electronic) IS - 0147-958X (Linking) VI - 40 IP - 1 DP - 2017 Feb 19 TI - Effect of obstructive sleep apnea on carotid artery intima media thickness related to inflammation. PG - E25-E33 AB - PURPOSE: Obstructive sleep apnea hypopnea syndrome (OSAHS) is an independent risk factor for atherosclerosis. To ascertain the effect of OSAHS on the development of atherosclerosis in Chinese OSAHS patients, we evaluated markers of atherosclerosis as well as vascular endothelial function and inflammation. METHODS: Chinese men with polysomnography-diagnosed OSAHS were subgrouped into mild-moderate (n = 28) and severe (n = 54) OSAHS groups on the basis of apnea hypopnea index (AHI) scores. The control group was made up of 30 healthy men. Atherosclerosis was assessed by carotid artery intima-media thickness (IMT) of both sides, flow-mediated dilation (FMD), and inflammation by interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), vascular endothelial growth factor (VEGF), and monocyte chemoattractant protein-1 (MCP-1) levels. RESULTS: Linear regression analysis was used to identify significant associations among risk factors and carotid IMT. The following parameters were significantly higher in patients with severe OSAHS than in the control group: waking triglycerides, total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, blood uric acid, blood glucose, IL-6 and hs-CRP. FMD in severe OSAHS patients was lower than in the control group. AHI score, waking hs-CRP, waking oxidized low-density lipoprotein, blood glucose, and vascular endothelial growth factor (VEGF) level were positively associated with IMT. CONCLUSIONS: In Chinese male patients with severe OSAHS, the significantly higher carotid IMT and levels of inflammatory factors (IL-6 and hs-CRP) and lower FMD suggest that arterial endothelial damage and inflammation may play important roles in the development of atherosclerosis in OSAHS patients. FAU - Kong, Delei AU - Kong D AD - Department of Respiratory Disease, First Affiliated Hospital of China Medical University, Shenyang 110001, China. email@email.com. FAU - Qin, Zheng AU - Qin Z FAU - Wang, Wei AU - Wang W FAU - Kang, Jian AU - Kang J LA - eng PT - Clinical Trial PT - Journal Article DEP - 20170219 PL - Canada TA - Clin Invest Med JT - Clinical and investigative medicine. Medecine clinique et experimentale JID - 7804071 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (VEGFA protein, human) RN - 0 (Vascular Endothelial Growth Factor A) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adult MH - Asian People MH - Atherosclerosis/blood/diagnostic imaging/etiology MH - C-Reactive Protein/*metabolism MH - *Carotid Intima-Media Thickness MH - Chemokine CCL2/*blood MH - China MH - Humans MH - Inflammation MH - Interleukin-6/*blood MH - Male MH - Middle Aged MH - *Sleep Apnea, Obstructive/blood/complications/diagnostic imaging MH - Vascular Endothelial Growth Factor A/*blood EDAT- 2017/02/22 06:00 MHDA- 2017/12/08 06:00 CRDT- 2017/02/21 06:00 PHST- 2017/02/19 00:00 [received] PHST- 2017/02/21 06:00 [entrez] PHST- 2017/02/22 06:00 [pubmed] PHST- 2017/12/08 06:00 [medline] AID - 10.25011/cim.v40i1.28051 [doi] PST - epublish SO - Clin Invest Med. 2017 Feb 19;40(1):E25-E33. doi: 10.25011/cim.v40i1.28051.